The U.S. Food and Drug Administration on Monday declined to approve Atara Biotherapeutics’ cell therapy for a rare form of blood cancer, the company said, sending its…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/us-fda-declines-approve-ataras-therapy-rare-blood-cancer-2026a100010a?src=rss
Author :
Publish date : 2026-01-12 13:09:00
Copyright for syndicated content belongs to the linked Source.